Skip to Main Content

Author Details

Kenneth R Hess
The University of Texas MD Anderson Cancer Center
1986
438
98
PMIDPaper TitleJournal TitlePublished Year
37114244Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.Neurooncol Adv2023
37114244Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.Neurooncol Adv2023
36989609Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.J Clin Oncol2023
36989609Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.J Clin Oncol2023
32763059Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.Acad Radiol2022
32763059Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.Acad Radiol2022
34538550Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.Acad Radiol2022
34538550Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.Acad Radiol2022
32920733Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).Breast Cancer Res Treat2021
31924662Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.BMJ Support Palliat Care2021
32033821Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.Curr Probl Diagn Radiol2021
33721621Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.ESMO Open2021
34342274Structural and spectrophotometric investigation of two unnatural amino-acid altered chromophores in the superfolder green fluorescent protein.Acta Crystallogr D Struct Biol2021
32920733Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).Breast Cancer Res Treat2021
33289280High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.Oncologist2021
34965510Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.J Natl Compr Canc Netw2021
34377987Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.Neurooncol Adv2021
33721621Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.ESMO Open2021
34965510Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.J Natl Compr Canc Netw2021
34377987Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.Neurooncol Adv2021
34342274Structural and spectrophotometric investigation of two unnatural amino-acid altered chromophores in the superfolder green fluorescent protein.Acta Crystallogr D Struct Biol2021
32033821Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.Curr Probl Diagn Radiol2021
31924662Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.BMJ Support Palliat Care2021
33289280High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.Oncologist2021
31076332Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.Acad Radiol2020
32080210Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies.Sci Rep2020
31852833Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.Clin Cancer Res2020
32195353Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.Sci Adv2020
32195033Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.Am J Cancer Res2020
32423453Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.BMC Cancer2020
32191331Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.JAMA Netw Open2020
32188704Phase 2 study of pembrolizumab in patients with advanced rare cancers.J Immunother Cancer2020
32303619Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors.J Immunother Cancer2020
32298794Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data.Pract Radiat Oncol2020
32108973The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings.Breast J2020
31932214Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.Pancreatology2020
32219153Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice.NPJ Breast Cancer2020
31605794Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.J Thorac Oncol2020
33097651Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.ESMO Open2020
33097611Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.J Immunother Cancer2020
32868897Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials.Br J Cancer2020
32529146Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation.Adv Radiat Oncol2020
32747747Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.Br J Cancer2020
32916308Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.J Thorac Oncol2020
33114311Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer.Cancers (Basel)2020
32777736Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.Eur J Radiol2020
33051340Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.J Immunother Cancer2020
31076332Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.Acad Radiol2020
31371208Variation in Technical Quality of Breast MRI.Acad Radiol2020
31311772Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle Biopsy.Acad Radiol2020
  • 1 - 50 of 876

Recommended Authors

Keck School of Medicine of the University of Southern California
Career Start Year 2009
Number of shared co-authors 4
University of Virginia
Career Start Year 2002
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 12
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 6
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 5
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 23
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 7
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 7
Stanford University
Career Start Year 1996
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 10
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 6
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 11
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 2
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 6
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 3
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 14
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 11
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 5
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 2
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 49
University of Texas M.D. Anderson Cancer Center
Co-authored papers 46
The University of Texas MD Anderson Cancer Center
Co-authored papers 37
Co-authored papers 33
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 26
Co-authored papers 24
The University of Texas MD Anderson Cancer Center
Co-authored papers 20
The University of Texas MD Anderson Cancer Center
Co-authored papers 19
University of California san francisco
Co-authored papers 17
MD Anderson Cancer Center
Co-authored papers 17
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Co-authored papers 16
National Cancer Institute
Co-authored papers 15
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 12
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Co-authored papers 10
University of Virginia School of Medicine
Co-authored papers 9
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 9
Co-authored papers 9
Huntsman Cancer Institute, University of Utah
Co-authored papers 9
Weill Cornell School of Medicine
Co-authored papers 8
Co-authored papers 8
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Co-authored papers 7
NYU Grossman School of Medicine
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Co-authored papers 7
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 6
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 6